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Am J Med Genet Part B 174B:120–131.Social anxiety is a neurobehavioral trait characterized by fear and
reticence in social situations. Twin studies have shown that social
anxiety has a heritable basis, shared with neuroticism and extraver-
sion,butgenetic studieshaveyet todemonstraterobustriskvariants.
Weconductedgenomewideassociationanalysis (GWAS)of subjects
within the Army Study To Assess Risk and Resilience in Service-
members(ArmySTARRS)to (i)determineSNP-basedheritabilityof
social anxiety; (ii) discern genetic risk loci for social anxiety; and
(iii) determine shared genetic risk with neuroticism and extraver-
sion. GWAS were conducted within ancestral groups (EUR, AFR,
LAT)using linear regressionmodels foreachof the threecomponent
studies in Army STARRS, and then meta-analyzed across studies.
SNP-based heritability for social anxiety was significant (h2g¼ 0.12,
P¼ 2.17 104 in EUR). One meta-analytically genomewide sig-
nificant locus was seen in each of EUR (rs708012, Chr 6: BP
36965970, P¼ 1.55 108; beta¼ 0.073) and AFR (rs78924501,
Chr 1: BP 88406905, P¼ 3.58 108; beta¼ 0.265) samples. Social
anxiety in Army STARRS was significantly genetically correlated
(negatively) with extraversion (rg¼0.52, se¼ 0.22, P¼ 0.02) but
not with neuroticism (rg¼ 0.05, se¼ 0.22, P¼ 0.81) or with an
anxiety disorder factor score (rg¼ 0.02, se¼ 0.32, P¼ 0.94) from
external GWAS meta-analyses. This first GWAS of social anxiety
confirms a genetic basis for social anxiety, shared with extraversion
but possibly less so with neuroticism.  2017 Wiley Periodicals, Inc.
Key words: anxiety; extraversion; neuroticism; social anxiety;
social phobia2017 Wiley Periodicals, Inc. 120
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Social anxiety is a dispositional trait that involves emotional
discomfort and reticence in situations where an individual is
subject to the scrutiny of others [Craske and Stein, 2016]. Social
anxiety disorder (SAD) is characterized by severe anxiety in social
situations, which are therefore often avoided, resulting in distress
and/or functional impairment [Heimberg et al., 2014]. SAD
is among the most common of the anxiety disorders, with a
12-month prevalence in the range of 5–8% and lifetime prevalence
8–12% [Ruscio et al., 2008]. It also has an early age of onset, and is
associated with the frequent subsequent accrual of comorbid
mental health problems such as, major depression and substance
use disorders [Stein and Stein, 2008].
Relatively little is known about the genetics of either social
anxiety or SAD [Stein and Gelernter, 2014]. We have shown in
prior studies that there is a heritable basis to social anxiety [Stein
et al., 2002] and SAD [Stein et al., 2001], and completed a genetic
linkage study consistent with the expected polygenicity [Gelernter
et al., 2004]. A recent meta-analysis of 13 cohorts (42,585 subjects)
showed that genetic and non-shared environmental factors explain
most of the individual differences for both social anxiety as a trait
and social anxiety as a disorder [Scaini et al., 2014]. Although
several candidate gene studies have reported associations with SAD
and related traits (e.g., shyness) [Arbelle et al., 2003; Smoller et al.,
2008], none has been satisfactorily replicated [Stein and Gelernter,
2014].
The purpose of the present study is to use genomewide associa-
tion methods to elucidate the genetic architecture of social anxiety.
To the best of our knowledge, this is the first GWAS specifically
focused on social anxiety. SAD is considered by some to be a
temperamental extreme of social anxiety, though factors other than
severity may play a role in distinguishing a normal-range trait from
disorder [Campbell-Sills et al., 2015]. There is no doubt, however,
that social anxiety is a core feature of SAD and, as such, a better
understanding of the biological basis of the former will contribute
to deeper knowledge about the pathophysiology of the latter [Fox
and Kalin, 2014].
Patients with SAD are also known to score very low on the
personality trait extraversion (i.e., they are extremely “intro-
verted”) [Bienvenu et al., 2004; Jylha et al., 2009; Watson and
Naragon-Gainey, 2014]. Accordingly, there may be value inTABLE I. Social Anxiety Factor Scores (by Ancestry
NSS1 (N¼ 7519)
N Mean SD N
Population
European American 4728 0.179 0.893 180
African American 1350 0.107 0.936 399
Latino American 1441 0.157 0.890 494
Sex (% male) 82.5
Age (years) 21.0 3.3exploring the genetic relationship between extraversion—a trait
that has been the subject of a recent, large, genetic meta-analysis
[van den Berg et al., 2016]—and social anxiety. This approach is
compatible with the notion of studying an “endophenotype” for
SAD, as well as with the Research Domain Criteria (RDoC) tactic
of studying mental disorders by focusing on their basic underly-
ing dimensions [Cuthbert, 2015].
Another personality trait, neuroticism—the recent subject of two
large genetic meta-analyses [Genetics of Personality Consortium
et al., 2015; Smith et al., 2016]—is thought to underliemany anxiety
and depressive disorders, and the evaluation of its genetic relation-
ship to social anxiety would also be informative. We also explored
the genetic relationshipof social anxiety to ananxietydisorder factor
score derived in a large anxiety disorder GWAS meta-analysis
[Otowa et al., 2016]. As a “negative control” we also determined
the genetic relationship of social anxiety with Alzheimer’s disease
[Lambert et al., 2013].
Lastly, given the well-characterized phenotype of hyper-socia-
bility and low social anxiety in Williams Syndrome (WS) [Morris,
2010; Barak and Feng, 2016], we reasoned that scrutiny of this
region might reveal associations with social anxiety. We therefore,
paid particular attention to the WS Region (7q11.23 [70–76 Mb])
in our analyses.METHODS
Subjects
Detailed information about the design and conduct of Army
STARRS is available in a separate report [Ursano et al., 2014].
The recruitment, consent, human subject, and data protection
procedures were approved by all collaborating organizations.
New soldier study (NSS). TheNSS was carried out among new
soldiers at the start of their basic training at one of three Army
InstallationsbetweenApril 2011andNovember2012.Of39,784NSS
participants who completed the computerized self-administered
questionnaire (SAQ), 33,088 (83.2%) provided blood samples.
Genotyping was conducted on samples from the first half of the
cohort, from which samples were selected based on phenotype
(enriched for probable cases of PTSD, Major Depressive Disorder,
Generalized Anxiety Disorder, and suicidality, and then including
controls with none of these disorders) (NSS1;N¼ 7,999).When the) and Sex and Age Distributions in the Samples
NSS2 (N¼ 2700) PPDS (N¼ 7109)
Mean SD N Mean SD
7 0.240 0.912 4733 0.157 0.889
0.154 0.939 873 0.180 0.848
0.259 0.901 1503 0.180 0.882
78.7 94.0
20.3 3.2 26.0 5.9
122 AMERICAN JOURNAL OF MEDICAL GENETICS PART Bremaining half of the cohort collection was completed, we selected a
subset (focused on post-traumatic stress disorder and suicidal
behaviors as principal targets for Army STARRS) for genotyping
(NSS2; N¼ 2,835).
Pre/post-deployment survey (PPDS). The PPDS is a multi-
wave panel survey that collected baseline data (T0) from US Army
soldiers in three Brigade Combat Teams (BCTs) during the first
quarter of 2012, within approximately 6 weeks of their deployment
to Afghanistan. 7,927 PPDS soldiers with eligible SAQ responses
were genotyped for GWAS.FIG. 1. Distribution of social anxiety factor scores in the
combined NSS1 and PPDS samples with a normal distribution
overlay.Demographics
The population, sex, and age composition of our analyzed sample is
shown in Table I. As expected, the PPDS subjects were older than
the new recruits in the NSS. Social anxiety factor scores and
standard deviations (SD) are as shown.Measures
The SAQ included a computerized version of the Composite
International Diagnostic Interview screening scales (CIDI-SC)
[Kessler and Ustun, 2004]. Four survey items were identified as
having content validity consistent with social anxiety. These
items, each scored from one (exactly like me) through five
(not at all like me) were: “I am much more shy then most
people;” “I am pretty quiet around people I don’t know well;”
“I get embarrassed easily,” and “I am an outgoing social person”
(this item was reverse scored). Also included was a fifth survey
item consisting of a single yes/no question (coded 5/1) with face
validity for SAD: “Were you ever in your life so painfully shy or
scared of social situations, (e.g., attending a party, speaking to
strangers, eating in public), that you avoided social situations
whenever you could?”).
Factor analysis was used to determine the dimensionality of the
five social anxiety items using a random sample of individuals from
the NSS1 and PPDS (including all ethnic groups, therefore yieldingTABLE II. SNP-Based Heritability of Social Anxie
h2g SE (h
2
g)
All samples
EUR 0.12 0.033
AFR 0.12 0.134
LAT 0.21 0.102
Male
EUR 0.14 0.037
AFR 0.17 0.174
LAT 0.19 0.117
Female
EUR 0.15 0.316
AFR 0.28 0.490
LAT 0.67 0.627
h2g, SNP-based heritability; SE, standard error; CI, confidence interval; EUR, European American; AFR, Af
samples model additionally adjusted for gender.a larger sample than analyzed here in the GWAS). The full sample
(n¼ 14,592) was split in half to create training and testing datasets
(n¼ 7,296 each). Exploratory factor analyses conducted using the
training dataset, followed by confirmatory factor analyses con-
ducted using the testing dataset both supported a unidimensional
measurement model. Measurement invariance was assessed
between the NSS1 and PPDS. The analyses indicated non-invariant
item thresholds between the NSS1 and PPDS samples that was
remedied by adding age as a covariate. Final parameter estimates
and factor scores were computed for the combined NSS and PPDS
sample (NSS1 and PPDS shown in Fig. 1).DNA Genotyping, Imputation, and Population
Stratification Adjustment
Detailed information on genotyping, genotype imputation,
population assignment, and principal component analysis forty (Meta-Analysis Across NSS1, NSS2, PPDS)
P-value 95%CI
2.17 104 0.05 0.18
0.176 0.14 0.38
0.020 0.01 0.41
8.77 105 0.07 0.21
0.148 0.17 0.52
0.047 0.04 0.42
0.323 0.47 0.77
0.291 0.68 1.24
0.158 0.55 1.90
rican American; LAT, Latino American. All models adjusted for 10 PCs and study components. The all
TABLE III. NSS1, NSS2, and PPDS GWAS Meta-Analysis Results at P< 106
CHR BP SNP A1 (MAF) A2 BETA P
AFR
1 88406905 rs78924501 T (0.09) C 0.265 3.58 108
EUR
6 36949527 rs2293390 C 0.0613 4.80 1007
6 36965970 rs708012 T (0.32) C 0.0732 1.55 108
LAT
7 49136131 rs35200331 T (0.148) C 0.1482 2.25 107
7 70464765 rs74820377 T (0.186) C 0.1859 7.71 107
11 89078387 rs60391512 T (0.390) C 0.3900 7.48 107
12 108618081 rs117328207 T (0.641) C 0.6412 4.94 107
ALL
1 88406905 rs78924501 T (0.241) C 0. 2414 1.97 107
6 97374850 rs13203153 A (0.061) G 0. 0606 3.08 107
6 97391272 rs2223614 A (0.062) C 0. 0619 2.40 107
6 97404417 rs34663994 A (0.058) C 0. 0583 8.32 107
MAF,minor allele frequency.
P< 5 108
STEIN ET AL. 123population stratification adjustment are included in our previous
report [Stein et al., 2016] and in Supplementary Materials. Whole
blood samples were shipped to Rutgers University Cell and DNA
Repository (RUCDR), where they were frozen for later DNA
extraction using standard methods. NSS1 and PPDS samples
were genotyped using the Illumina OmniExpressþ Exome array
with additional custom content. NSS2 samples were genotyped on
the Ilumina PsychChip.
Relatedness testing was carried out with PLINK v1.90 [Purcell
et al., 2007; Chang et al., 2015] and pairs of subjects with p of>0.2
were identified; one member of each relative pair was removed at
random. Genotype imputation was performed with a 2-step
pre-phasing/imputation approach with a reference multi-ethnic
panel from 1,000Genomes Project (August 2012 phase 1 integrated
release; 2,186 phased haplotypes with 40,318,245 variants). We
removed SNPs that were not present in the 1,000 Genomes Project
reference panel, had non-matching alleles to 1,000 Genome Project
reference, or had ambiguous, unresolvable alleles (AT/GC SNPs
with minor allele frequency [MAF]>0.1). A total of 664,457 SNPs
for the Illumina OmniExpress array and 360,704 for the Illumina
PsychChip entered the imputation procedure.
Since the Army STARRS subjects are from various ancestral
backgrounds, we first assigned our samples into major population
groups (European [EUR], African [AFR], or Latino [LAT]) (see
Supplementary Materials for details of population assignment
procedure; also see [Stein et al., 2016]). We excluded an Asian
[ASI] group that was too small for separate analysis based on
principal components (PCs). We then obtained PCs within each
population group for population stratification adjustment (see also
Supplementary Materials). We performed the following quality
control (QC) procedure to obtain the genotype data for population
assignment and principal component analysis (PCA). We kept
autosomal SNPs with missing rate <0.05; kept samples with
individual-wise missing rate <0.02; kept SNPs with missing rate<0.02; and kept SNPs with missing rate difference between PTSD
cases and controls<0.02 (tominimize the bias due to differences in
genotyping across PTSD cases and controls according to our
sampling scheme). After QC, we merged our study samples with
HapMap3 samples. We kept SNPs with minor allele frequency
(MAF) >0.01 and performed LD pruning at R2> 0.02. Finally, we
excluded SNPs in the MHC region (Chr 6:25-35Mb) and Chr 8
inversion (Chr 8:7–13Mb).Statistical Analysis
GCTA [Yang et al., 2011] with imputed data (modified from
[Chen et al., 2015; Yang et al., 2015]) was used to estimate the
proportion of variance in social anxiety scores explained by
common SNPs (i.e., SNP-heritability, h2g). We calculated the
genetic relationship matrix with PLINK v1.90 on combined
samples across three studies within each of the three populations
(EUR, LAT, and AFR). We estimated h2g of social anxiety with
linear mixed models implemented in GCTA software, adjusted
for 10 PCs, study, and gender. We further stratified the sample by
gender and estimated gender-specific h2g. P-value and 95%
confidence intervals (CI) were calculated for each h2g estimate.
Given the small proportion of women in our sample, the
calculation of female-specific h2g estimate is likely to be
underpowered and should be interpreted in that light. Finally,
we performed stratified LDSC to detect enrichment of h2g in
functional annotation domains. We used 24 predefined annota-
tion domains as described in [Finucane et al., 2015]. We
estimated the enrichment of h2g for each functional annotation
domain with block jackknife standard error.
PLINK v1.90 [Purcell et al., 2007; Chang et al., 2015] was used to
perform genomewide association tests for social anxiety factor
scores (SOCANX) on imputed SNP dosage with linear regression
adjusted for the top 10 within-population principal components
FIG. 2. Manhattan plots of NSS1, NSS2, and PPDS meta-analysis in (a) African American samples, identifying genome-wide significant
association for social anxiety with rs78924501 on Chr 1 (lGC¼ 1.013). (b) European American samples, identifying a genome-wide significant
association for social anxiety with rs708012 on Chr 6 (lGC¼ 1.020).
124 AMERICAN JOURNAL OF MEDICAL GENETICS PART B(PCs). We considered adjusting these analyses for other traits that
influenced the sampling in NSS1 and NSS2, but the complexity of
those sampling schemes (e.g., enriched for multiple disorders) did
not lend itself to the derivation of a suitable set of covariates; this
may be considered a limitation of the current analyses. We filtered
out SNPs with MAF< 0.01 or imputation quality score
(INFO)< 0.8. GWAS was conducted in the three studies (NSS1,
NSS2, and PPDS) separately within each of the three ancestral
groups (EUR, AFR, LAT) and then meta-analyzed within ancestry
group, but across studies. We report fixed-effects models as our
primary analysis in the Results, but random-effects models yieldedvirtually identical results and I2 values and P-values for
heterogeneity across studies supported the use of fixed-effects
models (see Supplementary Materials).
Meta-analysis was conducted using an inverse variance-
weighted fixed effects model in PLINK. A P-value of 5 108
was used as the threshold for genomewide significance. The
meta-analysis of all three studies within ancestral groups is the
primary analysis.
We used LD score regression (LDSC) [Bulik-Sullivan et al.,
2015] to test the genetic correlation between social anxiety and
other traits in European samples using recently published
FIG. 3. Regional plots of (a, top panel) rs78924501 on Chr 1 in African American subjects and (b, bottom panel) rs708012 on Chr 6 in
European American subjects.
STEIN ET AL. 125meta-analytic GWAS for anxiety disorders [Otowa et al., 2016],
neuroticism [Genetics of Personality Consortium et al., 2015], and
extraversion [van den Berg et al., 2016], respectively. As a negative
control, we also tested the genetic correlation between social
anxiety and Alzheimer’s disease [Lambert et al., 2013].We performed gene-set analysis (GSA), or pathway analysis,
using software INRICH [Lee et al., 2012] to identify enriched
association signals of social anxiety in gene sets aggregated in
biological pathways. We used the clumping functionality
(R2 threshold was 0.5) in PLINK1.9 to identify LD-independent
TABLE IV. LDSC Determination of Genetic Correlation in EUR
126 AMERICAN JOURNAL OF MEDICAL GENETICS PART Bregions based on index SNPs with P< 0.0001 in the final
meta-analysis in European American samples.Subjects of Social Anxiety Score with Other Traits (From External
Study Meta-analyses With Pubmed ID [PMID] Shown)
Phenotype PMID rg
SE
(rg) P
Anxiety disorder (factor
score)
26754954 0.02 0.32 0.94
Neuroticism 25993607 0.05 0.22 0.81
Extraversion 26362575 0.52 0.22 0.02
Alzheimer’s disease 24162737 0.06 0.23 0.79RESULTS
SNP-Based Heritability of Social Anxiety
Phenotype
We estimated SNP-based heritability (h2g) using GCTA [Yang
et al., 2011]. We found significant h2g estimates of 12% for social
anxiety (SOCANX), seen in the meta-analysis across studies in the
European American sample (P¼ 2.17 104; 95%CI: 0.05–0.18).
The h2g estimate is 12% (P¼ 0.176, 95% CI: 0.14–0.38) in the
African American sample and 21% (P¼ 0.020, 95% CI: 0.01–0.41)
in the Latino American sample, but neither was statistically signifi-
cant after multiple comparison correction. The male-specific h2g
estimate of social anxiety for European Americans is 14% with a
significant P-value of 8.77 105 (95% CI: 0.07–0.21), while
the female-specific h2g estimate is 15% with P-value of 0.323.
Details of these analyses, by ancestral group and sex, are included
in Table II.Enrichment of SNP-Based Heritability by
Functional Annotation
We estimated the enrichment of h2g by 24 main annotation
domains for social anxiety. The h2g for each of the 24 annotation
domains were simultaneous estimated using the association
analysis summary results from the meta-analysis of European
American samples in PPDS, NSS1, and NSS2. We did two func-
tional enrichment analyses, one based on the “full baseline model”
that is not cell type specific and the other that is central nervous
system (CNS) specific. Bothmodels showed very similar results and
we did not observe any significant enrichment of h2g by functional
annotation (See Supplementary Materials).Genomewide Association Analyses
One SNP on chromosome 1 (rs78924501, BP 88406905, P¼ 3.58
 108; beta¼ 0.265) was genomewide significantly associated
with SOCANX in the meta-analysis across the three studies in
the AFR subsample (Figs. 2a and 3a). One SNP on chromosome 6
(rs708012, BP 36965970, P¼ 1.55 108; beta¼ 0.073) was
genomewide significantly associated with SOCANX in the meta-
analysis across the three studies in the European American sample
(Figs. 2b and 3b). Whereas, these results were obtained using fixed
effects analysis, random effects analyses identified the same two
SNPs, respectively, as genomewide significant (see Supplementary
Materials). We did not find similar results for either SNP in the
other ancestry groups or in any of the trans-ethnic meta-analyses
(Table III; results at P< 106 shown).
Examination of the WS Region (Fig. 4) revealed several SNPs
that were nominally significantly associated with SOCANX, the
strongest association being found for rs56081032 (MAF¼ 0.17,
P¼ 3.55 103). However, a set-based permutation test of
association of SNPs in the WS region (defined as 72.5–74.5
MB), conducted using PLINK [Purcell et al., 2007], showed nostatistically significant association between the WS region and
social anxiety (data available from authors upon request).Genetic Correlations
LDSC. Social anxiety was significantly—and negatively—
genetically correlated with extraversion [van den Berg et al.,
2016] (rg¼0.52, se¼ 0.22, P¼ 0.02) in European samples. Ge-
netic correlations with neuroticism [Genetics of Personality
Consortium et al., 2015] and with an cccanxiety disorders quanti-
tative factor score (derived from amultivariate analysis combining
information across various anxiety disorder clinical phenotypes)
[Otowa et al., 2016] were of smaller magnitude (rg¼ 0.05–0.22)
and not statistically significant (Table IV). Genetic correlation with
Alzheimer’s disease [Lambert et al., 2013], intended as a “negative
control,” was as anticipated, small, and not statistically significant
(rg¼ 0.06, se¼ 0.23, P¼ 0.79).Gene Set Analysis (GSA)
We identified 103 genomic regions showed association signals with
social anxiety through PLINK clumping function. We tested for
enrichment of genes from a certain gene-set (pathway) in these 103
genomic regions.Weperformed the enrichment test based on 3,425
pathways from the Gene Ontology (GO) database, each with 5–200
genes. Pathways showed suggestive enrichment P-value (nominal
P< 0.05) are shown (Table V); no pathway had a statistically
significant P-value after multiple testing correction.DISCUSSION
This study is to the best of our knowledge, the first GWAS of social
anxiety conducted to date. Consistent with prior twin studies, but
using GWAS methods to calculate SNP-based heritability, we
confirmed that social anxiety has a heritable basis. The magnitude
of heritability we found is in the range of that found using the same
methods for other traits such as neuroticism (15%) [Smith et al.,
2016]. According to twin studies, genetic factors that influence
individual variation in extraversion and neuroticism appear to
account entirely for the genetic risk for SAD [Bienvenu et al., 2007],
highlighting the value of examining the molecular genetic
determinants of both these traits as a means to identifying risk
FIG. 4. Regional plot of rs56081032 (within the Williams syndrome region) in European Americans.
STEIN ET AL. 127loci for SAD. A large meta-analysis of GWAS datasets for extra-
version identified no genomewide significant loci, nor did a
significant SNP-based heritability estimate emerge [van den
Berg et al., 2016]. Recent meta-analyses of genomewide association
studies (GWAS) have revealed genomewide significant loci for
neuroticism [Genetics of Personality Consortium et al., 2015;
Smith et al., 2016] and it might be expected that risk loci for these
traits might overlap with those for SAD.
Interestingly, consistent with the high negative phenotypic
correlation between social anxiety and extraversion seen in the
literature [Bienvenu et al., 2004; Jylha et al., 2009; Watson andTABLE V. Gene-Set Analysis Using INRICH to E
Pathway Go ID
Estrogen_metabolic_process GO:0008210
Luteinization GO:0001553
S-adenosylhomocysteine_metabolic_process GO:0046498
BRCA1-A_complex GO:0070531
Lung_alveolus_development GO:0048286
Anterior/posterior_pattern_formation GO:0009952
Phosphoinositide_3-kinase_cascade GO:0014065
Insulin-like_growth_factor_binding GO:0005520
Respiratory_gaseous_exchange GO:0007585
Chromatin_remodeling GO:0006338
Positive_regulation_of_actin_filament_polymerization GO:0030838
Multicellular_organism_growth GO:0035264
Size, number of genomic regions defining the pathway; Overlap, number of LD-independent social anxie
P-value for enrichment with 1,000,000 permutations; Corrected P-value, P-value after multiple testNaragon-Gainey, 2014], using LDSC we found evidence in our
European samples of a strong and statistically significant negative
genetic correlation between social anxiety in our study and extra-
version in a published GWAS meta-analysis dataset [van den Berg
et al., 2016]. In contrast, we failed to find evidence of a significant
genetic correlation between social anxiety in our study and
neuroticism in a published neuroticism GWAS meta-analysis
dataset [Genetics of Personality Consortium et al., 2015]. It is
conceivable that failure to find genetic correlations between social
anxiety and neuroticism is a result of inadequate power, although
the external GWAS for neuroticism and extraversion were bothnrich Association Signals for Social Anxiety
Size Overlap P-value Corrected P-value
10 4 0.0002 0.127
7 3 0.0017 0.617
6 3 0.0046 0.876
6 3 0.018 0.994
23 3 0.023 0.997
96 7 0.024 0.997
10 3 0.033 0.999
19 3 0.035 0.999
27 4 0.037 0.999
45 5 0.041 0.999
14 3 0.043 1.000
25 3 0.046 1.000
ty associated regions that overlap with the genomic regions defining the pathway; P-value, nominal
ing correction.
128 AMERICAN JOURNAL OF MEDICAL GENETICS PART Blarge (N> 60,000 subjects) and, in fact, included the same subjects.
But it is also possible that despite considerable shared phenotypic
variance, the shared genetic variance between social anxiety and
extraversion is larger than that shared between social anxiety and
neuroticism. Larger social anxiety samples will be needed to resolve
this issue.
There have also been GWAS studies of internalizing disorders
(which would include SAD) [Hettema et al., 2015] and GWAS
[Otowa et al., 2014] and meta-analytic reports of GWAS [Otowa
et al., 2016] of anxiety disorders (which would also include SAD).
As such, risk loci detected in those studies could be relevant to
social anxiety and SAD, but this possibility cannot be determined
from those studies because they did not specifically examine social
anxiety phenotypes. We failed, in fact, to find a significant genetic
correlation between an anxiety disorder factor from the aforemen-
tioned anxiety disorder GWAS [Otowa et al., 2016] and social
anxiety. It is uncertain to what extent genetic risk for the dimen-
sional trait studied here maps onto the disorder (i.e., SAD). It will
be important for future research to examine the risk loci identified
in our study (rs78924501 onChr1 in the AFR sample, and rs708012
onChr6 in the EUR sample) for their possible associationwith SAD
and other anxiety-related disorders. Of particular note, the Chr1
risk SNP is downstream from CCBL2, also known as KYAT3
(Kynurenine Aminotransferase 3), which encodes an aminotrans-
ferase involved in the metabolism of tryptophan. KYAT3 variation
has previously been described in relation to risk for major depres-
sion [Claes et al., 2011]. Abnormal brain tryptophan metabolism
and its possible relationship to altered serotonin synthesis and
signaling have been at the forefront of recent hypotheses about the
pathophysiology of SAD [Frick et al., 2015; Stein and Andrews,
2015], with another tryptophan metabolic pathway gene, TPH2
(tryptophan hydroxylase 2) recently implicated as a risk locus
[Furmark et al., 2016]. Taken together, these observations call
for additional studies of a role for genetic variation in serotonin
signaling pathways in social anxiety and SAD.
Individuals with WS, caused by hemizygous microdeletion of a
portion of 7q11.23, have a behavioral phenotype that includes
extreme gregariousness and hypersociability [Morris, 2010; Barak
and Feng, 2016]. As such, WS presents a remarkable mirror image
of the behavioral phenotype of SAD. Accordingly, we decided to
pay particular attention to the Williams region as part of our
analysis. A region-based test of SNPs in this region failed to find
evidence of significant association. Nevertheless, we found nomi-
nally significant association with several SNPs in the Williams
region (themost significant of whichwas rs56081032 (MAF¼ 0.17,
P¼ 3.55 103). This SNP is approximately 600 Kb upstream
from another gene in the Williams Region, GTF2I, variants in
which have been suggested to influence extraversion and anxiety
proneness in healthy adults [Jabbi et al., 2015; Swartz et al., 2015].
These observations suggest that it may be fruitful to scrutinize the
Williams regionmore carefully, in order to fully test the hypothesis
that copy-number variants in this region might influence risk for
disorders associated with elevated social anxiety (e.g., SAD).
Our results should be interpreted in light of several additional
limitations. First, samples sizes—especially within ancestral groups
—are likely to be insufficiently powered to detect loci of modest
effect. Much larger samples will be needed to discern genes ofsmaller effect. Second, the publicly available external GWAS
datasets to which we had access consisted solely of individuals
of European descent, and it is therefore possible that the con-
clusions we have drawn regarding genetic correlations may apply
only to that tested ancestral group. Third, it is important to
remember that our focus here has been on social anxiety as a
continuous trait. Although we believe that understanding the
genetic architecture of social anxiety and its relationship to other
traits will be informative toward the understanding of a disorder
marked by heightened levels of social anxiety, namely SAD, this is
an empirical question that can only be answered by direct applica-
tion of our findings to samples of patients with SAD and other
anxiety disorders. Fourth, our sample ismostlymale, but SADhas a
strong female predominance. It may be that the genetic factors
influencing SAD vary by sex, although our failure to obtain a
statistically significant heritability estimate in women is almost
certainly due to low power for this sex-specific analysis. Fifth, our
sample is entirely military, and it is possible that generalizability to
the general population is limited.
In summary, this first GWAS of social anxiety confirms a genetic
basis for social anxiety, shared with extraversion but possibly less so
with neuroticism. Scrutiny of the Williams Region for copy-
number variants relevant to social anxiety should be attempted.
Such studies hold the promise of leading to a better understanding
of risk for early-onset disorders such as SAD and related
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